Test ID: DAGL
Gliadin (Deamidated) Antibody, IgA, Serum
Method Description
Describes how the test is performed and provides a method-specific reference
IgA antibodies to deamidated gliadin peptides are detected by enzyme-linked immunosorbent assay by binding to purified peptides adsorbed to the wells of a microtiter plate. Peptides are bound to the wells under conditions that preserve the antigens in their native states. Prediluted controls and diluted patient sera are added to separate wells allowing antibodies to bind to the deamidated gliadin peptides. Unbound sample constituents are washed away and horseradish peroxidase-labeled antihuman IgA antibody conjugate is added to each well. After a second incubation, unbound enzyme-labeled conjugate is washed away and bound conjugate is detected by adding tetramethylbenzidine (TMB) chromogenic substrate. After a final incubation, colored product is measured spectrophotometrically and the absorbance compared to the low positive calibrator. The intensity of color is directly proportional to the level of IgA antibodies to deamidated gliadin peptides expressed in arbitrary units.(Package insert: QUANTA Lite Gliadin IgA II INOVA Diagnostics, Inc., San Diego, CA)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Saturday; 4 p.m.


